Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Heart

Retrieve available abstracts of 101 articles:
HTML format

Single Articles

    November 2022
  1. WILKINSON C, Rockwood K
    Frailty assessment in the management of cardiovascular disease.
    Heart. 2022;108:1991-1995.

  2. GUPTA D, Ding WY, Calvert P, Williams E, et al
    Cryoballoon Pulmonary Vein Isolation as First-Line Treatment for Typical Atrial Flutter.
    Heart. 2022 Nov 17. pii: heartjnl-2022-321729. doi: 10.1136/heartjnl-2022-321729
    PubMed     Abstract available

  3. WEBER C, Hung J, Hickling S, Li I, et al
    Emergent readmission and long-term mortality risk after incident atrial fibrillation hospitalisation.
    Heart. 2022 Nov 16. pii: heartjnl-2022-321560. doi: 10.1136/heartjnl-2022-321560
    PubMed     Abstract available

  4. WALDMANN V, Khairy P
    Atrial fibrillation in Ebstein anomaly: weathering the storm.
    Heart. 2022 Nov 15. pii: heartjnl-2022-321876. doi: 10.1136/heartjnl-2022-321876

  5. MARTIN DE MIGUEL I, Madhavan M, Miranda WR, Connolly HM, et al
    Prognostic implications of atrial fibrillation in adults with Ebstein anomaly.
    Heart. 2022 Nov 11. pii: heartjnl-2022-321493. doi: 10.1136/heartjnl-2022-321493
    PubMed     Abstract available

  6. KITAI T, Nabeta T, Naruse Y, Taniguchi T, et al
    Comparisons between biopsy-proven versus clinically diagnosed cardiac sarcoidosis.
    Heart. 2022;108:1887-1894.
    PubMed     Abstract available

  7. AEBERSOLD H, Serra-Burriel M, Foster-Wittassek F, Moschovitis G, et al
    Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohort.
    Heart. 2022 Nov 4. pii: heartjnl-2022-321520. doi: 10.1136/heartjnl-2022-321520.
    PubMed     Abstract available

    October 2022
  8. CASO V, de Groot JR, Sanmartin Fernandez M, Segura T, et al
    Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2022 Oct 31. pii: heartjnl-2022-321114. doi: 10.1136/heartjnl-2022-321114
    PubMed     Abstract available

  9. LANE DJ, Grunau B, Kudenchuk P, Dorian P, et al
    Bayesian analysis of amiodarone or lidocaine versus placebo for out-of-hospital cardiac arrest.
    Heart. 2022;108:1777-1783.
    PubMed     Abstract available

  10. LYNGBAKKEN MN, Ronningen PS, Solberg MG, Berge T, et al
    Prediction of incident atrial fibrillation with cardiac biomarkers and left atrial volumes.
    Heart. 2022 Oct 19. pii: heartjnl-2022-321608. doi: 10.1136/heartjnl-2022-321608
    PubMed     Abstract available

  11. RAMLAKHAN KP, Kauling RM, Schenkelaars N, Segers D, et al
    Supraventricular arrhythmia in pregnancy.
    Heart. 2022;108:1674-1681.
    PubMed     Abstract available

    September 2022
  12. HENDRIKS JM, Elliott AD, Middeldorp ME, Sanders P, et al
    Contributing factors to personalised medicine in atrial fibrillation.
    Heart. 2022 Sep 29. pii: heartjnl-2022-321553. doi: 10.1136/heartjnl-2022-321553

  13. LAWIN D, Lawrenz T, Marx K, Danielsmeier NB, et al
    Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Heart. 2022;108:1623-1628.
    PubMed     Abstract available

  14. MSZAR R, Friedman DJ, Ong E, Du C, et al
    Sex-based differences in atrial fibrillation ablation adverse events.
    Heart. 2022 Sep 14. pii: heartjnl-2022-321192. doi: 10.1136/heartjnl-2022-321192
    PubMed     Abstract available

  15. MARSCHNER S, von Huben A, Zaman S, Reynolds HR, et al
    Pregnancy-related cardiovascular conditions and outcomes in a United States Medicaid population.
    Heart. 2022;108:1524-1529.
    PubMed     Abstract available

    August 2022
  16. VAN DER VELDEN RMJ, Pluymaekers NAHA, Dudink EAMP, Luermans JGLM, et al
    Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation.
    Heart. 2022 Aug 29. pii: heartjnl-2022-321346. doi: 10.1136/heartjnl-2022-321346
    PubMed     Abstract available

  17. SANCHEZ-QUINTANA D, Anderson RH, Tretter JT, Cabrera JA, et al
    Anatomy of the conduction tissues 100 years on: what have we learned?
    Heart. 2022;108:1430-1437.
    PubMed     Abstract available

    July 2022
  18. PARALE C, Velayutham R, Anantharaj A
    Tachycardia in a young man: does pulse oximetry give a clue?
    Heart. 2022;108:1266-1330.

  19. NGUYEN BO, Weberndorfer V, Crijns HJ, Geelhoed B, et al
    Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation.
    Heart. 2022 Jul 20. pii: heartjnl-2022-321027. doi: 10.1136/heartjnl-2022-321027
    PubMed     Abstract available

  20. VILALTA V, Cediel G, Mohammadi S, Lopez H, et al
    New-onset persistent left bundle branch block following sutureless aortic valve replacement.
    Heart. 2022 Jul 16. pii: heartjnl-2022-321191. doi: 10.1136/heartjnl-2022-321191
    PubMed     Abstract available

  21. KANY S, Cardoso VR, Bravo L, Williams JA, et al
    Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank.
    Heart. 2022 Jul 14. pii: heartjnl-2022-321196. doi: 10.1136/heartjnl-2022-321196
    PubMed     Abstract available

  22. KIM HJ, Chang DH, Kim SO, Kim JK, et al
    Left atrial appendage preservation versus closure during surgical ablation of atrial fibrillation.
    Heart. 2022 Jul 13. pii: heartjnl-2022-320939. doi: 10.1136/heartjnl-2022-320939
    PubMed     Abstract available

    June 2022
  23. MARROQUIN L, Tirado-Conte G, Pracon R, Streb W, et al
    Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure.
    Heart. 2022;108:1098-1106.
    PubMed     Abstract available

  24. AVILA P, Calvo D, Tamargo M, Uribarri A, et al
    Association of age with clinical features and ablation outcomes of paroxysmal supraventricular tachycardias.
    Heart. 2022;108:1107-1113.
    PubMed     Abstract available

  25. TAN HL, Remme CA
    Sudden cardiac death: recognising hidden risk among women versus men.
    Heart. 2022;108:992-993.

    May 2022
    Management of cardiac arrest in the cardiac catheterisation laboratory: guidelines tailored to place and occasion.
    Heart. 2022;108:907-908.

  27. OTTO CM
    Heartbeat: can cardiogenetics reduce adverse events due to catecholaminergic polymorphic ventricular tachycardia?
    Heart. 2022;108:816-818.

  28. POSTEMA PG, van der Werf C
    Catecholaminergic polymorphic ventricular tachycardia: differences in inheritance and implications for patients, families and future studies.
    Heart. 2022;108:820-821.

  29. SHIMAMOTO K, Ohno S, Kato K, Takayama K, et al
    Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1.
    Heart. 2022;108:840-847.
    PubMed     Abstract available

  30. MARSMAN EMJ, Postema PG, Remme CA
    Brugada syndrome: update and future perspectives.
    Heart. 2022;108:668-675.
    PubMed     Abstract available

  31. HAYDOCK P, Camm AJ
    History and evolution of pacing and devices.
    Heart. 2022;108:794-799.
    PubMed     Abstract available

    April 2022
  32. ROSEBOOM E, Maass AH
    Inherited and modifiable factors need to be identified in young patients with atrioventricular block.
    Heart. 2022 Apr 5. pii: heartjnl-2022-320841. doi: 10.1136/heartjnl-2022-320841.

  33. KOMEN J, Pottegard A, Hjemdahl P, Mantel-Teeuwisse AK, et al
    Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds.
    Heart. 2022;108:613-618.
    PubMed     Abstract available

  34. MORITA S, Malik AH, Kuno T, Ando T, et al
    Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion.
    Heart. 2022;108:606-612.
    PubMed     Abstract available

  35. HOLT A, Blanche P, Zareini B, Rasmussen PV, et al
    Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants.
    Heart. 2022;108:626-632.
    PubMed     Abstract available

  36. HIGUCHI K, Bhargava M
    Management of premature ventricular complexes.
    Heart. 2022;108:565-572.

    March 2022
  37. PARK YJ, Park JW, Yu HT, Kim TH, et al
    Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs.
    Heart. 2022 Mar 24. pii: heartjnl-2021-320601. doi: 10.1136/heartjnl-2021-320601
    PubMed     Abstract available

  38. RAATIKAINEN P, Lassila R
    COVID-19: another reason for anticoagulation in patients with atrial fibrillation.
    Heart. 2022 Mar 21. pii: heartjnl-2022-320845. doi: 10.1136/heartjnl-2022-320845

  39. GILL S, Bunting KV, Sartini C, Cardoso VR, et al
    Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis.
    Heart. 2022 Mar 11. pii: heartjnl-2021-320417. doi: 10.1136/heartjnl-2021-320417
    PubMed     Abstract available

  40. HANDY A, Banerjee A, Wood AM, Dale C, et al
    Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort.
    Heart. 2022 Mar 10. pii: heartjnl-2021-320325. doi: 10.1136/heartjnl-2021-320325
    PubMed     Abstract available

  41. DYSSEKILDE JR, Christiansen MK, Johansen JB, Nielsen JC, et al
    Familial risk of atrioventricular block in first-degree relatives.
    Heart. 2022 Mar 4. pii: heartjnl-2021-320411. doi: 10.1136/heartjnl-2021-320411.
    PubMed     Abstract available

  42. FRANKE KB, Mahajan R
    Cardiac oxidative stress: a potential tool for risk stratification in cardiac sarcoidosis.
    Heart. 2022;108:410-411.

  43. YOSHITOMI R, Kobayashi S, Yano Y, Nakashima Y, et al
    Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis.
    Heart. 2022;108:429-437.
    PubMed     Abstract available

    February 2022
  44. EVERS-DORPFELD S, Aeschbacher S, Hennings E, Eken C, et al
    Sex-specific differences in adverse outcome events among patients with atrial fibrillation.
    Heart. 2022 Feb 8. pii: heartjnl-2021-320122. doi: 10.1136/heartjnl-2021-320122.
    PubMed     Abstract available

  45. OTTO CM
    Heartbeat: bleeding risk in atrial fibrillation patients on non-vitamin K oral anticoagulant medications.
    Heart. 2022;108:243-245.

  46. GUPTA A, Arora GK, Isser HS
    An elderly woman with recurrent syncope.
    Heart. 2022;108:257-324.

  47. MORRONE D, De Caterina R
    Bleeding risk score: limits and practicability.
    Heart. 2022;108:246-248.

    January 2022
  48. TUTAREL O, Baris L, Budts W, Gamal Abd-El Aziz M, et al
    Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC).
    Heart. 2022;108:117-123.
    PubMed     Abstract available

  49. VITALE G, Ditaranto R, Graziani F, Tanini I, et al
    Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy.
    Heart. 2022;108:54-60.
    PubMed     Abstract available

    December 2021
  50. OTTO CM
    Heartbeat: lower risk of dementia with a direct oral anticoagulatant, compared to a vitamin K antagonist, for patients with atrial fibrillation.
    Heart. 2021;107:1847-1849.

  51. DING WY, Mahida S
    Wide complex tachycardia: differentiating ventricular tachycardia from supraventricular tachycardia.
    Heart. 2021;107:1995-2003.

    November 2021
  52. OTTO CM
    Heartbeat: ECG approaches to early detection of atrial fibrillation.
    Heart. 2021;107:1765-1767.

    October 2021
  53. HIMELFARB JD, Shulman H, Olesovsky CJ, Rumman RK, et al
    Atrial fibrillation following transcatheter atrial septal defect closure: a systematic review and meta-analysis.
    Heart. 2021 Oct 21. pii: heartjnl-2021-319794. doi: 10.1136/heartjnl-2021-319794
    PubMed     Abstract available

  54. DEYELL MW, Hawkins NM
    Odd couple: premature ventricular contractions and heart failure.
    Heart. 2021 Oct 19. pii: heartjnl-2021-319986. doi: 10.1136/heartjnl-2021-319986

  55. CADOGAN SL, Powell E, Wing K, Wong AY, et al
    Anticoagulant prescribing for atrial fibrillation and risk of incident dementia.
    Heart. 2021 Oct 13. pii: heartjnl-2021-319672. doi: 10.1136/heartjnl-2021-319672
    PubMed     Abstract available

  56. CHUA W
    Clearing the cognitive cloud: direct oral anticoagulants or vitamin K antagonists for reducing dementia risk in patients with atrial fibrillation?
    Heart. 2021 Oct 13. pii: heartjnl-2021-320138. doi: 10.1136/heartjnl-2021-320138

  57. NADARAJAH R, Alsaeed E, Hurdus B, Aktaa S, et al
    Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis.
    Heart. 2021 Oct 4. pii: heartjnl-2021-320036. doi: 10.1136/heartjnl-2021-320036.
    PubMed     Abstract available

  58. ZAMAN J, Agarwal S
    Management of ventricular tachycardia storm.
    Heart. 2021;107:1671-1677.

    September 2021
  59. BARNETT-GRINESS O, Stein N, Kotler A, Saliba W, et al
    Novel bleeding prediction model in atrial fibrillation patients on new oral anticoagulants.
    Heart. 2021 Sep 21. pii: heartjnl-2021-319702. doi: 10.1136/heartjnl-2021-319702
    PubMed     Abstract available

  60. KASHOU A, Noseworthy P
    Predicting incident atrial fibrillation in sinus rhythm: more than just trusting the 'black box'.
    Heart. 2021 Sep 7. pii: heartjnl-2021-319385. doi: 10.1136/heartjnl-2021-319385.

  61. LIMPITIKUL WB, Dewland TA, Vittinghoff E, Soliman E, et al
    Premature ventricular complexes and development of heart failure in a community-based population.
    Heart. 2021 Sep 7. pii: heartjnl-2021-319473. doi: 10.1136/heartjnl-2021-319473.
    PubMed     Abstract available

  62. NASER JA, Pislaru S, Stan MN, Lin G, et al
    Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves' disease.
    Heart. 2021 Sep 6. pii: heartjnl-2021-319752. doi: 10.1136/heartjnl-2021-319752.
    PubMed     Abstract available

    August 2021
  63. BLAAUW Y, Mulder B, Rienstra M
    Is catheter ablation of atrial fibrillation as first-line treatment ready for prime time?
    Heart. 2021 Aug 12. pii: heartjnl-2021-319832. doi: 10.1136/heartjnl-2021-319832

  64. KANY S, Schnabel R
    Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation.
    Heart. 2021 Aug 12. pii: heartjnl-2021-319830. doi: 10.1136/heartjnl-2021-319830

  65. SCHNABEL RB, Wallenhorst C, Engler D, Blankenberg S, et al
    Refined atrial fibrillation screening and cost-effectiveness in the German population.
    Heart. 2021 Aug 10. pii: heartjnl-2020-318882. doi: 10.1136/heartjnl-2020-318882
    PubMed     Abstract available

  66. TOOLEY JE, Perez MV
    Role of digital health in detection and management of atrial fibrillation.
    Heart. 2021 Aug 3. pii: heartjnl-2020-318262. doi: 10.1136/heartjnl-2020-318262.
    PubMed     Abstract available

  67. OTTO CM
    Heartbeat: improved quality of life and reduced healthcare utilisation after catheter ablation in patients with drug-resistant paroxysmal atrial fibrillation.
    Heart. 2021;107:1271-1273.

    July 2021
  68. FUKAYA H, Ako J, Yasuda S, Kaikita K, et al
    Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319321. doi: 10.1136/heartjnl-2021-319321
    PubMed     Abstract available

  69. IMBERTI JF, Ding WY, Kotalczyk A, Zhang J, et al
    Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319496. doi: 10.1136/heartjnl-2021-319496
    PubMed     Abstract available

  70. PHILLIPS K, Subramanian A, Thomas GN, Khan N, et al
    Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018.
    Heart. 2021 Jul 5. pii: heartjnl-2021-319338. doi: 10.1136/heartjnl-2021-319338.
    PubMed     Abstract available

    June 2021
  71. CHEN TH, Chu YC, Ou SM, Tarng DC, et al
    Associations of atrial fibrillation with renal function decline in patients with chronic kidney disease.
    Heart. 2021 Jun 30. pii: heartjnl-2021-319297. doi: 10.1136/heartjnl-2021-319297
    PubMed     Abstract available

  72. MULDER BA, Rienstra M, Van Gelder IC, Blaauw Y, et al
    Update on management of atrial fibrillation in heart failure: a focus on ablation.
    Heart. 2021 Jun 4. pii: heartjnl-2020-318081. doi: 10.1136/heartjnl-2020-318081.
    PubMed     Abstract available

  73. SANZ-GARCIA A, Cecconi A, Vera A, Camarasaltas JM, et al
    Electrocardiographic biomarkers to predict atrial fibrillation in sinus rhythm electrocardiograms.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319120. doi: 10.1136/heartjnl-2021-319120.
    PubMed     Abstract available

  74. MINNERS J, Jander N
    Consecutive, index and representative beats: obtaining reliable information despite an irregular heart rhythm.
    Heart. 2021;107:862-863.

  75. BRIGNOLE M, Rivasi G
    New insights in diagnostics and therapies in syncope: a novel approach to non-cardiac syncope.
    Heart. 2021;107:864-873.
    PubMed     Abstract available

  76. PARKER WA, Storey RF
    Antithrombotic therapy for patients with chronic coronary syndromes.
    Heart. 2021;107:925-933.

    May 2021
  77. WILDE AAM, Amin AS, Postema PG
    Diagnosis, management and therapeutic strategies for congenital long QT syndrome.
    Heart. 2021 May 26. pii: heartjnl-2020-318259. doi: 10.1136/heartjnl-2020-318259
    PubMed     Abstract available

  78. KAWAJI T, Ogawa H, Hamatani Y, Kato M, et al
    Association of inverted T wave during atrial fibrillation rhythm with subsequent cardiac events.
    Heart. 2021 May 26. pii: heartjnl-2021-319199. doi: 10.1136/heartjnl-2021-319199
    PubMed     Abstract available

  79. NICOLI CD, O'Neal WT, Levitan EB, Singleton MJ, et al
    Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
    Heart. 2021 May 24. pii: heartjnl-2021-319122. doi: 10.1136/heartjnl-2021-319122
    PubMed     Abstract available

  80. ROSSIDES M, Kullberg S, Grunewald J, Eklund A, et al
    Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden.
    Heart. 2021 May 21. pii: heartjnl-2021-319129. doi: 10.1136/heartjnl-2021-319129
    PubMed     Abstract available

  81. ELVAN A
    It's all about improvement of quality of life and reduction of disease burden in atrial fibrillation ablation.
    Heart. 2021 May 20. pii: heartjnl-2021-319382. doi: 10.1136/heartjnl-2021-319382

  82. BOSMAN LP, Te Riele ASJM
    Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification.
    Heart. 2021 May 14. pii: heartjnl-2021-319113. doi: 10.1136/heartjnl-2021-319113
    PubMed     Abstract available

  83. CHOI Y, Lee Y, Kim SH, Kim S, et al
    Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantation.
    Heart. 2021 May 14. pii: heartjnl-2020-318750. doi: 10.1136/heartjnl-2020-318750
    PubMed     Abstract available

  84. GUPTA D, Ding WY
    Contemporary management of persistent atrial fibrillation.
    Heart. 2021 May 14. pii: heartjnl-2020-317422. doi: 10.1136/heartjnl-2020-317422

  85. CHUA W, Fabritz L
    Heart failure in patients with atrial fibrillation: why it matters now more than ever.
    Heart. 2021 May 13. pii: heartjnl-2021-319145. doi: 10.1136/heartjnl-2021-319145

  86. RUTHERFORD OW, Jonasson C, Ghanima W, Soderdahl F, et al
    Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation.
    Heart. 2021 May 11. pii: heartjnl-2020-318753. doi: 10.1136/heartjnl-2020-318753
    PubMed     Abstract available

  87. GUPTA D, Vijgen J, Potter T, Scherr D, et al
    Quality of life and healthcare utilisation improvements after atrial fibrillation ablation.
    Heart. 2021 May 5. pii: heartjnl-2020-318676. doi: 10.1136/heartjnl-2020-318676.
    PubMed     Abstract available

  88. JOLOBE O
    Next frontier is inclusion of high-grade carotid artery stenosis in the CHA2DS2 Vasc score.
    Heart. 2021;107:767.

    Stroke risk in rheumatic heart disease.
    Heart. 2021;107:694-696.

  90. FAN P, Zhang Y, Lu YT, Yang KQ, et al
    Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy.
    Heart. 2021;107:836-841.
    PubMed     Abstract available

    April 2021
  91. SANTOS IS, Bensenor IM
    Cardiovascular health and atrial fibrillation.
    Heart. 2021 Apr 15. pii: heartjnl-2021-319253. doi: 10.1136/heartjnl-2021-319253

  92. LEE JH, Yang PS, Yu HT, Kim TH, et al
    Association of cardiovascular health and incident atrial fibrillation in elderly population.
    Heart. 2021 Apr 2. pii: heartjnl-2020-318858. doi: 10.1136/heartjnl-2020-318858.
    PubMed     Abstract available

  93. YEO C, Wang Y, Tan VH
    Wide complex tachycardia captured on smartwatch.
    Heart. 2021;107:626-684.

  94. GEURINK K, Holmes D, Ezekowitz MD, Pieper K, et al
    Patterns of oral anticoagulation use with cardioversion in clinical practice.
    Heart. 2021;107:642-649.
    PubMed     Abstract available

  95. SPARROW R, Sanjoy S, Choi YH, Elgendy IY, et al
    Racial, ethnic and socioeconomic disparities in patients undergoing left atrial appendage closure.
    Heart. 2021 Apr 1. pii: heartjnl-2020-318650. doi: 10.1136/heartjnl-2020-318650.
    PubMed     Abstract available

    February 2021
    Biomarkers for detection of a thrombus in the left atrial appendage: the search for the grail?
    Heart. 2021;107:176-177.

    January 2021
  97. SINGH T, Newby DE
    Is the fear of disease worse than the disease itself?
    Heart. 2021;107:91-92.

    October 2020
  98. MULDER BA, Rienstra M, Blaauw Y
    Evaluation and treatment of premature ventricular contractions in heart failure with reduced ejection fraction.
    Heart. 2020 Oct 19. pii: heartjnl-2020-317491. doi: 10.1136/heartjnl-2020-317491
    PubMed     Abstract available

    September 2020
  99. IHSAN J, Khand A, Adlan AM
    Ventricular storm following late presentation acute myocardial infarction.
    Heart. 2020;106:1399-1448.

    May 2020
  100. KIM WK, Kim HJ, Kim JB, Jung SH, et al
    Exclusion versus preservation of the left atrial appendage in rheumatic mitral valve surgery.
    Heart. 2020 May 6. pii: heartjnl-2019-316387. doi: 10.1136/heartjnl-2019-316387.
    PubMed     Abstract available

    January 2020
  101. TAN TC, Nunes MCP, Handschumacher M, Pontes-Neto O, et al
    Left atrial cross-sectional area is a novel measure of atrial shape associated with cardioembolic strokes.
    Heart. 2020 Jan 24. pii: heartjnl-2019-315964. doi: 10.1136/heartjnl-2019-315964
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.